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AbstrACt 
Objective Despite considerable improvements, 5-year 
survival rates for colon cancer in the UK remain poor when 
compared with other socioeconomically similar countries. 
Variation in 5-year survival can be partly explained by 
higher rates of death within 3 months of diagnosis in the 
UK. This study investigated the characteristics of patients 
who died within 3 months of a diagnosis of colon cancer 
with the aim of identifying specific patient factors that 
can be addressed or accounted for to improve survival 
outcomes.
Design A retrospective case–control study design was 
applied with matching on age, sex and year diagnosed. 
Patient, disease, clinical and service characteristics of 
patients diagnosed with colon cancer in a UK region 
(2005–2010) who survived less than 3 months from 
diagnosis (cases) were compared with patients who 
survived between 6 and 36 months (controls). Patient and 
clinical data were sourced from general practice notes and 
hospital databases 1–3 years prediagnosis.
results Being older (aged ≥78 years) and living in 
deprivation quintile 5 (OR=2.64, 95% CI 1.15 to 6.06), 
being unmarried and living alone (OR=1.64, 95% CI 1.07 
to 2.50), being underweight compared with normal weight 
or obese (OR=3.99, 95% CI 1.14 to 14.0), and being older 
and living in a rural as opposed to urban area (OR=1.96, 
95% CI 1.21 to 3.17) were all independent predictors of 
early death from colon cancer. Missing information was 
also associated with early death, including unknown stage, 
histological type and marital/accommodation status after 
accounting for other factors.
Conclusion Several factors typically associated with 
social isolation were a recurring theme in patients 
who died early from colon cancer. This association 
is unexplained by clinical or diagnostic pathway 
characteristics. Socially isolated patients are a key target 
group to improve outcomes of the worst surviving patients, 
but further investigation is required to determine if being 
isolated itself is actually a cause of early death from colon 
cancer.
IntrODuCtIOn
Despite considerable improvements, UK 
survival rates for colon cancer remain poor 
by international comparison, with higher 
5-year survival reported in Norway, Sweden, 
Canada and Australia1 and poorer survival 
in the UK compared with several coun-
tries reported in Eurocare.2 These deficits 
have largely been explained by survival at 
3 months postdiagnosis.3 Patients who survive 
beyond this period in the UK have similar 
5-year survival rates to their counterparts in 
better performing countries.1 Approximately 
19% of patients with colorectal cancer in 
the UK and 16% in Northern Ireland (NI) 
died within 3 months of diagnosis between 
2006 and 2008.4 5 It was estimated that if 
survival in England matched that of Norway, 
13.6% fewer patients would die within the 
3-month period.3 Generally poor survival is 
linked with a number of factors, including 
late-stage disease at diagnosis,6 poor patient 
fitness due to coexisting disease,7 and limited 
strengths and limitations of this study
 ► The study sample was generated from a high-qual-
ity population-based cancer registry system with 
relatively few death certificate only cases.
 ► Case–control design provided an efficient meth-
od of collecting data and allowed the development 
of a control group that was matched on important 
non-modifiable characteristics.
 ► Data used in this study predate the introduction of 
the national bowel cancer screening programme in 
this UK region, which should mitigate any improve-
ment in survival independently associated with 
bowel cancer screening.
 ► Survival of controls was restricted to a population of 
patients whose survival was less than 3 years and 
similar to the case population.
 ► The  study identified several characteristics which 
discriminated between cases and controls suggest-
ing that patients who die within the first few months 
of diagnosis are a specific patient cohort who re-
quires attention.
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availability of and access to high-quality investigations 
and treatment.8 
Reasons for diagnostic delay in colorectal cancer are 
well documented.9 Lower educational status10 11 and 
rural residence12 13 have been associated with delayed 
help-seeking. Additionally, stronger social networks have 
been associated with shorter diagnostic delay.14–16 Clinical 
characteristics also play a role. Patients with comorbid 
disease11 17 and/or multiple symptoms11 are less likely 
to delay compared with those with non-specific symp-
toms.17 18 Application of referral guidelines by general 
practitioners (GPs) has been shown to reduce delay,9 
while younger patients,13 19 those of lower socioeconomic 
status20 and frequent help-seekers10 16 were less likely to be 
referred. While bowel cancer screening was introduced in 
the UK in 200721 and in NI in 2011,22 the vast majority 
patients are diagnosed clinically23; therefore, the role of 
clinical decision making in early colon cancer diagnosis 
remains paramount.
The relationship between these factors and surviving 
past the first few months following a colon cancer diag-
nosis has not been adequately investigated, and their role 
in explaining international survival differences requires 
attention. The aim of this study was to investigate patient, 
clinical and disease factors associated with early death in 
patients with colon cancer in NI and to determine factors 
which might help to identify subgroups in the population 
for early diagnosis interventions.
MethODOlOgy
This study employed a retrospective, individually 
matched, case–control design involving a posthumous 
review of primary care physician or GP and electronic 
secondary care notes. The study design was guided by 
the principles of the Aarhus statement on early diagnosis 
research.24 Principles adhered to in this study include 
items 1–4, 7–9 and 20 of the Aarhus checklist. Date of 
initial cancer diagnosis is defined by the Northern Ireland 
Cancer Registry (NICR) as date of first tissue diagnosis in 
secondary care, not as symptom presentation in primary 
and/or secondary care.
Case and control definition and identification
Cases
Patients diagnosed with primary colon cancer (Interna-
tional Classification of Diseases, 10th Revision: C18) in 
NI between January 2005 and December 2010 (prior to 
the introduction of the national bowel cancer screening 
programme in this region) were identified using the 
NICR. Using death registrations, provided by the General 
Registrar Office, the status and survival of patients were 
determined. Cases were defined as patients with an 
observed survival of under 90 days following diagnosis 
date (as assigned by the NICR). A random sample of all 
eligible cases were selected using random number tables 
based on predefined power calculations.
Controls
Controls included patients with an observed survival 
lasting over 6 months and less than 3 years, leaving a 
3-month buffer between the survival rates of cases and 
controls. Controls were individually matched, using 
individual nearest neighbour matching,25 26 to cases by 
age (within 5-year age bands), sex and year of diagnosis 
(within 2-year groups). In both groups, patients with inci-
dent cancer identified by death certificate only (DCO) 
and patients with recurrence of a previous incident colon 
cancer were excluded.
exposure variables and covariates
Data items were identified through literature review, with 
items and categorisation defined in consultation with a 
clinical adviser, GP, a colorectal surgeon and an oncolo-
gist. Items were classified into seven areas: demographic 
factors acting as a surrogate for social isolation (marital 
status, accommodation status, NI Multiple Deprivation 
Measure quintile, rural/urban status), lifestyle (smoking 
and alcohol status, health-seeking activity including 
uptake of influenza vaccine and frequency of GP atten-
dance) and comorbidities (Charlson Comorbidity Index 
(CCI) score and psychiatric illnesses). These characteris-
tics were collected from information recorded between 
1 and 3 years before diagnosis. Marital and accommo-
dation status were merged in the final analysis due to 
multicollinearity.
Disease characteristics included symptoms in the year 
to diagnosis, and disease stage at diagnosis with histology, 
morphology and grade collected from pathology 
records held in the NICR, and GP and hospital episodes 
(including symptoms (classified as ‘vague’ or ‘alarm’ 
based on the National Institute for Health and Care 
Excellence Guidelines for Suspected Cancer Referral), 
clinician actions (number of GP episodes before diag-
nosis and referral) and investigations ordered). In 
addition, treatment (first treatment type, treatment 
intent, surgical resection (yes/no), radiotherapy (yes/
no), chemotherapy (yes/no)) and death (date, place 
and cause of death) information was  collected. Data 
were collected by two trained data abstractors under the 
guidance of a medically trained clinical adviser using a 
common bespoke proforma. Data were sourced from 
GP records, electronic hospital records including the 
hospital discharge records, multidisciplinary team and 
oncology data systems. Assuming β=0.8 and a two-sided 
test with a significance level of 5%, a sample size of n=960 
(480 cases matched to 480 controls) sufficiently powers 
this study to detect an OR of 2.1 for any risk factor with 
a prevalence of 5%, an OR of 1.8 for any risk factor with 
a prevalence of 10%, and an OR of 1.6 for any risk factor 
with a prevalence of 15%.
statistical methods
Data were analysed using STATA V.14. All missing data 
were categorised as unknown and included in the anal-
ysis. Univariate analysis involved cross-tabulation of all 
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categorical variables with case/control status. Conditional 
logistic regression was used to produce unadjusted ORs 
and associated 95% CIs to identify independent factors 
associated with early death. Patient characteristics that 
were deemed to be clinically significant and/or statisti-
cally significant at p<0.25 were included in a minimally 
adjusted multivariable model to test independence from 
other comorbidities, patient and disease characteristics. 
Stage and pathway to diagnosis characteristics (number 
of accident and emergency (A&E) and GP episodes in 
the 3 months preceding the diagnosis) were added to the 
models to assess the degree to which they explained vari-
ation in early death among different patient groups. Age 
(a binary classification around the median age (78 years; 
IQR=19) of cases) and sex-stratified univariate and multi-
variable analyses were undertaken to investigate differ-
ences in patterns in early death between these groups.
Patient and public involvement
Members of the public, including patients, were not 
involved in the design or analysis stages of this piece of 
non-interventional research, but research question was 
designed to explore the characteristics of patients who 
die early after a diagnosis of colon cancer.
results
There were 4358 colon cancer tumours between 2005 and 
2010 registered by the NICR. Of these, 743 (17%) related 
to patients who died within 3 months of diagnosis and 
1069 related to patients who died between 6 months and 
3 years. Following exclusions and sampling (figure 1), 
484 cases and the same number of matched controls were 
generated. There were no significant differences between 
cases included in the study and those not included (online 
supplementary table 1) regarding stage at diagnosis, 
deprivation quintile, age and survival. However, the study 
group included significantly more men than women, as 
well as fewer patients diagnosed in 2009 and 2010 due to 
resource constraints in data collection.
univariate analysis
Compared with married patients, the odds of early death 
were higher among single, widowed and those with 
unknown marital status (table 1). Those who lived alone, 
in nursing or residential care, or were living with another 
relative were more likely to die within 3 months compared 
with those living with a spouse/partner. The odds of early 
death were also higher in the most deprived communities 
(23%) compared with the least deprived (13%) (table 1).
Baseline GP consultation activity was not associated 
with early death. Regarding influenza vaccine uptake, it 
was not possible to identify patients who were invited for 
vaccination, although based on age alone 86% of cases 
were eligible. Approximately 70% took the vaccine at 
least once during the period of 1–3 years before diag-
nosis; 15% did not attend for their vaccination and atten-
dance for the remaining 18% was unknown. Patients who 
attended twice in the period of 1–3 years before diagnosis 
had lower odds of early death than patients who did not 
attend. Smoking status was not significantly associated 
with early death, with the exception of those who had an 
unknown smoking status (see table 1).
Being underweight (body mass index (BMI) <18.5) 
was strongly associated with early death compared with 
patients with a normal or elevated BMI. However, obesity 
was not associated with early death when compared with 
being non-obese (table 2). Comorbidity was common 
among patients who died early. Almost three-quarters 
(72%) had at least one comorbidity. CCI score was, 
however, not associated with early death when means were 
compared by way of t-test (the mean CCI score for cases 
was 4.75 compared with 4.90 for controls). Dementia was 
the only comorbidity within the CCI that was associated 
with early death—it was present in 8% of cases compared 
with 4% of controls (table 2).
Figure 1 Case inclusions and exclusions. DCO, death 
certificate only; NICR,  Northern Ireland Cancer Registry; PM, 
post mortem. 
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Regarding pre-existing psychiatric conditions, 1% of 
cases were recorded as having schizophrenia, 1% with a 
learning disability and 13% with anxiety or depression. 
None were significantly associated with early death. 
However, the small number of patients with ‘other’ 
psychiatric conditions had higher odds of early death 
Table 1 Demographic characteristics of cases and controls and associated ORs for early death and 95% CIs
Characteristics 
Case Control
OR* 95% CIn % n % 
Accommodation status 
  Spouse/Partner 156 32.2 233 48.1 1
  Nursing/Residential 48 9.9 23 4.8 3.93 2.18 to 7.09
  Sheltered dwelling 8 1.7 14 2.9 0.91 0.37 to 2.24
  Alone 156 32.2 152 31.4 1.74 1.23 to 2.45
  Lives with relative 53 11.0 40 8.3 2.32 1.41 to 3.82
  Unknown 63 13.0 22 4.6 5.32 3.00 to 9.43
Marital status 
  Married/Cohabiting 189 39.1 257 53.1 1
  Divorced 15 3.1 13 2.7 1.51 0.66 to 3.45
  Unknown 44 9.1 15 3.1 3.79 2.06 to 6.96
  Single 74 15.3 53 11.0 1.88 1.25 to 2.84
  Widowed 162 33.5 146 30.2 1.60 1.14 to 2.22
Urban/Rural status 
  Rural 178 63.2 166 65.7 1
  Urban 306 36.8 318 34.3 0.89 0.68 to 1.17
Deprivation quintile 
  Q1 (least deprived) 64 13.2 89 18.4 1
  Q2 95 19.6 92 19.0 1.45 0.76 to 1.74
  Q3 106 21.9 111 22.9 1.01 0.66 to 1.54
  Q4 110 22.7 102 21.1 1.49 0.99 to 2.24
  Q5 (most deprived) 109 22.5 90 18.6 1.47 0.95 to 2.27
Influenza vaccination uptake 
  No uptake 71 14.7 47 9.7 1
  ≥1 vaccination 324 66.9 345 71.3 0.63 0.43 to 0.94
  Unknown 89 18.4 92 19.0 0.65 0.40 to 1.05
Baseline consultation activity (tercile) 
  <11 149 30.8 156 32.2 1
  11–19 148 30.6 162 33.5 0.98 0.71 to 1.34
  ≥20 187 38.6 166 34.3 1.20 0.87 to 1.67
Smoking 
  Non-smoker 221 45.7 219 15.7 1
  Ex-smoker 141 29.1 175 36.2 0.76 0.55 to 1.04
  Current smoker 91 18.8 76 15.7 1.19 0.81 to 1.75
  Unknown 31 6.4 14 2.9 2.30 1.16 to 4.56
Alcohol consumption 
  Current drinker 154 31.8 175 36.2 1
  Ex-drinker 31 6.4 26 5.4 1.37 0.78 to 2.43
  Never drank 189 39.1 191 39.5 1.13 0.82 to 1.55
  Unknown 110 22.7 92 19.0 1.38 0.96 to 1.99
*Conditional logistic regression ORs for cases and controls matched on age, sex and year diagnosed.
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Table 2 Presence of individual comorbidities included in the Charlson score in cases and controls and associated clogit ORs 
and 95% CIs
Characteristics 
Case Control
OR* 95% CIn % n % 
Underweight 
  No 467 96.5 479 99.0 1
  Yes 17 3.5 5 1.0 3.4 1.25 to 9.22
Obese 
  No 425 87.8 420 86.8 1
  Yes 59 12.2 64 13.2 0.91 0.63 to 1.33
Dementia 
  No 445 91.9 462 95.5 1
  Yes 39 8.1 22 4.6 1.85 1.07 to 3.19
Hypertension 
  No 279 57.6 260 53.7 1
  Yes 205 42.4 224 46.3 0.84 0.6 to 1.10
Ischaemic heart disease 
  No 391 80.8 386 79.8 1
  Yes 93 19.2 98 20.3 0.94 0.68 to 1.29
Parkinson’s disease 
  No 473 97.7 477 98.6 1
  Yes 11 2.3 7 1.5 1.57 0.61 to 4.05
Valvular heart disease 
  No 422 87.2 416 86.0 1
  Yes 62 12.8 68 14.1 0.89 0.61 to 1.31
Myocardial infarction 
  No 429 88.6 436 90.1 1
  Yes 55 11.4 48 9.9 1.16 0.78 to 1.72
Congestive heart failure 
  No 459 94.8 451 93.2 1
  Yes 25 5.2 33 6.8 0.72 0.41 to 1.27
Peripheral vascular disease 
  No 452 93.4 462 95.5 1
  Yes 32 6.6 22 4.6 1.53 0.86 to 2.72
Cerebrovascular disease 
  No 433 89.5 440 90.9 1
  Yes 51 10.5 44 9.1 1.18 0.77 to 1.81
COPD 
  No 402 83.1 397 82.0 1
  Yes 82 16.9 87 18.0 0.98 0.64 to 1.50
Connective tissue disorder 
  No 441 91.1 440 90.9 1
  Yes 43 8.9 44 9.1 0.98 0.64 to 1.50
Diabetes without complications 
  No 420 86.8 429 88.6 1
  Yes 64 13.2 55 11.4 1.20 0.81 to 1.77
Peptic ulcer 
Continued
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(table 3). Compared with Dukes stage A, Dukes stage 
D and unknown stage were associated with early death. 
Unknown histological type, unspecified anatomical site 
and undetermined grade were also associated with early 
death. Patients with a family history of colorectal cancer 
had lower odds of early death compared with patients 
without a family history (table 4).
Multivariable analysis
Unknown marital status, being single, widowed, divorced 
and living alone were all associated with early death 
compared with patients who were married/cohabiting 
after adjusting for other patient characteristics and comor-
bidities. Regarding socioeconomic status, a deprivation 
gradient for early death was apparent in older people 
living within quintile 5. This relationship existed for all 
patients in quintile 4. These socially deprived groups 
had higher odds of early death compared with the least 
deprived after adjusting for other factors (table 5). Being 
underweight between 1 and 3 years before diagnosis was 
significantly associated with early death in multivariable 
analysis. Unspecified histology and Dukes stage D disease 
remained positively associated with early death in multi-
variable analysis. Additional models that adjusted for 
pathway characteristics (attendance at A&E and number 
of GP consultations prior to diagnosis) did not explain 
the association between marital status and early death 
(p<0.01). Influenza vaccination attendance and baseline 
consultation activity, dementia, psychiatric illness and 
smoking status were not significantly associated with early 
death in multivariable analysis.
Characteristics 
Case Control
OR* 95% CIn % n % 
  No 446 92.2 456 94.2 1
  Yes 38 7.9 28 5.8 1.40 0.84 to 2.34
Liver disease 
  No 481 99.4 481 99.4 1
  Yes 3 0.6 3 0.6 1 0.20 to 4.95
Hemiplegia/Paraplegia 
  No 484 100.0 482 99.6 1
  Yes 0 0.0 2 0.4 – – 
Renal disease 
  No 441 91.1 449 92.8 1
  Yes 43 8.9 35 7.2 1.24 0.79 to 1.94
Diabetes with complications 
  No 465 96.1 460 95.1 1
  Yes 19 3.9 24 5.0 0.79 0.43 to 1.45
Cancer 
  No 468 96.7 456 94.2 1
  Yes 16 3.3 28 5.8 0.57 0.31 to 1.06
Leukaemia 
 No 482 99.6 482 99.6 1
  Yes 2 0.4 2 0.4 1.00 0.14 to 7.10
Lymphoma 
  No 482 99.6 483 99.8 1
  Yes 2 0.4 1 0.2 2.00 0.18 to 22.06
Severe liver disease 
  No 484 100 483 99.8 1
  Yes 0 0 1 0.2 – – 
Metastatic cancer 
  No 451 93.2 436 90.0 1
  Yes 33 6.8 48 9.9 0.64 0.40 to 1.04
*Conditional logistic regression ORs for cases and controls matched on age, sex and year diagnosis.
Table 2 Continued 
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Consistent patterns were observed among men and 
women when data were stratified by sex, although the asso-
ciation between deprivation and early death was strongly 
pronounced among women and not present among men. 
Age stratification showed the odds of early death were 
higher for those living in rural areas compared with urban 
areas among patients aged ≥78 years. This association was 
not apparent in those aged <78. Otherwise, there were no 
significant differences in the factors associated with early 
death between those aged <78 and those aged ≥78 (see 
table 5—only data for ≥78 shown).
DIsCussIOn
summary of findings
This study investigated the characteristics of patients 
who died within 3 months of a diagnosis of colon cancer, 
by way of univariate and multivariate analyses, with the 
aim of identifying specific patient factors that can be 
addressed or accounted for to improve survival outcomes. 
Social isolation was identified as a common characteristic 
of early death in patients with colon cancer. The different 
forms of social isolation studied included living alone 
and being unmarried (as opposed to cohabiting with a 
partner), residing in more deprived communities (as 
opposed to living in quintile 1–2 communities), living 
in a rural area when elderly (as opposed to an urban 
area), and having dementia or a psychiatric illness. Each 
of these factors was comparatively associated with early 
death. Previous studies suggested that poorer outcomes 
for unmarried people and those living alone were medi-
ated through weak social support,27 which exerted its 
influence on outcomes through later presentation.28 This 
view is consistent with several other studies that reported 
more negative cancer beliefs,29 lower symptom awareness 
and greater perceived barriers to GP help-seeking among 
this group.30 While weaker social support has previously 
been associated with later stage disease,31 32 in this study, 
despite the collection of a range of detailed pathway 
and treatment variables, the association between marital 
status, accommodation status and early death remained 
unexplained. Other studies suggested biopsychosocial 
explanations for poorer cancer outcomes in unmar-
ried patients with cancer, including chronic stress33 and 
weaker immune response.34 Marital status and accommo-
dation status have an important association with cancer 
and health outcomes generally,35 yet it is a research area 
that remains relatively underinvestigated.
As in other studies, deprivation quintile was associated 
with early death, with a gradient in the odds of early 
death with increasing deprivation score.4 36 37 However, 
unlike other studies, this association seems restricted to 
women. Like marital/accommodation status, there was 
little evidence from this study suggesting that the associa-
tion between deprivation and early death is explained by 
characteristics of the pathway to diagnosis as the associa-
tions persisted after adjusting for attendance at A&E in 
the pathway to diagnosis, Dukes stage and GP episodes in 
the 3 months to diagnosis. There is no direct biological 
basis for an association between deprivation and survival. 
Mediating factors may include lower performance status 
due to higher tobacco consumption,38 lower uptake of 
treatments due to fatalistic cancer beliefs39 or differen-
tial access to services.40 The association between rural 
residence and early death among the oldest patients was 
independent of deprivation and strongly significant. This 
is likely to relate to either isolation, access to services or 
both. This is a well-defined target group for early diag-
nosis interventions, but further study is required to inves-
tigate the link between lack of social contact and cancer 
survival if one exists.
Table 3 Psychiatric illness among cases and controls and associated clogit ORs and 95% CIs
Characteristics 
Case Control
OR* 95% CIn % n % 
Learning disability 
  No 479 99.0 482 99.6 1
  Yes 5 1.0 2 0.4 1.24 0.85 to 1.79
Anxiety/Depression 
  No 419 86.6 425 87.8 1
  Yes 65 13.4 59 12.2 1.13 0.76 to 1.70
Schizophrenia 
  No 480 99.2 479 99.0 1
  Yes 4 0.8 5 1.0 0.80 0.22 to 2.98
Other psychiatric disorder 
  No 470 97.1 480 99.2 1
  Yes 14 2.9 4 0.8 3.50 1.15 to 10.63
*Conditional logistic regression ORs for cases and controls matched on age, sex and year diagnosis.
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Similar to previous work on early colorectal cancer 
death,4 a consistent feature associated with early death 
was that of incomplete data due to limited diagnostic 
testing. Missing histology, stage, grade and anatomical 
site may be explained by very ill patients not receiving 
complete investigation. These characteristics may there-
fore be viewed as confounding by indication; as opposed 
to explaining early death, the associations are explained 
by early death. The relationships between unknown 
marital status, accommodation and outcomes are more 
difficult to explain. Despite the fact that GP records 
and secondary care databases were searched, and the 
information relates to a period over a year prior to diag-
nosis of cancer, a strong association with early death was 
observed indicating the data were not missing at random. 
Missing data on living status, smoking status and alcohol 
consumption were also associated with early death in 
univariate analysis. Further work is required to explain 
Table 4 Disease characteristics among cases and controls and associated ORs and 95% CIs
Characteristics 
Case Control
OR* 95% CIn % n % 
Anatomical location 
  Ascending 52 10.7 57 11.8 1
  Caecum 93 19.2 136 28.1 0.83 0.52 to 1.29
  Other 90 18.6 93 19.2 1.19 0.73 to 1.93
  Descending 29 6.0 18 3.7 1.97 0.97 to 3.99
  Sigmoid colon 95 19.6 132 27.3 0.86 0.54 to 1.37
  Not specified 125 25.8 48 9.9 2.96 1.75 to 5.02
Histological type 
  Adenocarcinoma 256 52.9 384 79.3 1
  Mucinous 14 2.9 28 5.8 0.91 0.45 to 1.81
  Not specified 198 40.9 60 12.4 5.62 3.80 to 8.34
  Other 16 3.3 12 2.5 1.68 0.77 to 3.67
Metastases 
  None 37 7.6 64 13.2 1
  Bone 9 1.9 1 0.2 17.2 2.48 to 143.6
  Liver 134 27.7 108 22.3 2.37 1.42 to 3.95
  Lung 14 2.9 10 2.1 2.55 1.01 to 6.38
  Other 27 5.6 23 4.8 2.17 1.07 to 4.41
  Unknown 263 54.3 278 57.4 1.77 1.10 to 2.84
Dukes stage 
  A 8 1.7 19 3.9 1
  B 46 9.5 85 17.6 1.37 0.54 to 3.48
  C 47 9.7 127 26.2 1.02 0.41 to 2.52
  D 160 33.1 140 28.9 2.96 1.23 to 7.14
  Unknown 233 46.1 113 23.4 5.65 2.30 to 13.91
Grade (differentiation) 
  Well/Moderate 93 19.2 190 39.3 1
  Poor/Undifferentiated 40 8.3 57 11.8 1.45 0.89 to 2.36
  Not determined 351 72.5 237 50.0 3.32 2.38 to 4.62
Colorectal polyps 
  No 467 10.7 57 11.8 1
  Yes 17 19.2 136 28.1 0.80 0.42 to 1.54
Bowel cancer family history 
  No 459 25.8 48 9.9 1
  Yes 25 6.0 18 3.7 0.52 0.31 to 0.88
*Conditional logistic regression ORs for cases and controls matched on age, sex and year diagnosis.
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this relationship, with possible areas for investigation 
including the patient–practitioner relationship.
While comorbidity was a common feature of patients in 
this study, we did not find it associated with dying within 
3 months of diagnosis. Previous studies have observed 
that comorbidity exerted the greatest influence in the 
later phases of the survival pathway,41 although CCI score 
has been observed as an independent indicator of early 
death elsewhere.4 We had matched cases and controls on 
age, and as comorbidity is strongly linked to age this may 
have reduced our ability to detect this as an independent 
factor. In addition, being underweight had a strong inde-
pendent association with early death. This was measured 
between 1 and 3 years before diagnosis, and it is likely 
either related to disease progressing over a longer time 
period or to poorer performance status. However, as only 
17 cases were described as underweight, it explains less 
than 4% of the total early deaths.
While the CCI was not associated with early death, 
dementia and other psychiatric illness, as individual 
comorbid conditions, were associated with early death. 
However, in multivariable analysis, these relationships did 
not persist. Those with dementia were more likely to have 
missing data on stage and anatomical location, perhaps 
suggesting that these patients were less likely to be inves-
tigated for their disease. Similar findings have been 
reported in other colon cancer studies, with dementia 
associated with poorer colorectal cancer outcomes, later 
stage disease42 and less invasive investigation.43 The rela-
tionship between other psychiatric illness and early death 
was also attenuated by stage, again suggesting a role of 
diagnostic intervals on the pathway to diagnosis explaining 
early death. Underlying causes of delay may relate to 
symptom recognition by carer, patient, practitioner, as 
well as patient communication or competing healthcare 
priorities. A key objective of this study was to determine if 
patient health-seeking characteristics were associated with 
early death following colon cancer diagnosis. Uptake of 
the influenza vaccine, baseline consultation activity and 
non-attendance at appointments were identified as three 
easily captured indicators of health-seeking behaviour. It 
was hypothesised that patients with more regular or more 
compliant health-seeking behaviour would have better 
outcomes than those without, mediated through longer 
diagnostic intervals and later stage disease.
With regard to health-seeking behaviour, although 
attendance for the influenza vaccine was inversely asso-
ciated with early death, this association was not signifi-
cant in multivariable analysis. While attendance for the 
vaccine may be considered an indicator of health compli-
ance, it is likely to reflect various health attitudes and 
behaviours, with previous UK studies reporting several 
social and cultural factors that were associated with influ-
enza vaccination uptake, as well as perception regarding 
health status and susceptibility to influenza.44 The other 
indicator of health-seeking, frequent GP attendance, 
was correlated with comorbidity in this study, a rela-
tionship reported in several other research studies.10 45 
Although ex-smokers were identified in univariate anal-
ysis as having non-significantly lower odds of early death, 
this association was largely explained in the minimally 
adjusted model with little evidence to suggest that poorer 
outcome among smokers is real. While previous studies 
have demonstrated a significant association between alco-
hol-related hospital admissions and early death following 
a colorectal cancer diagnosis,37 this association was not 
observed in the current study possibly because this study 
was unable to discriminate between heavy and moderate 
alcohol use.
strengths and weaknesses
The study sample was generated from a high-quality popu-
lation-based cancer registry system with relatively few 
DCO cases46 with full access to general practice records 
and hospital clinical records. While missing data were a 
feature of the study, rather than acting as an impediment 
to our understanding of characteristics of early death, 
this appears to be one of the defining features of this 
patient group. Another recent study of early death has 
reported a similar pattern of high levels of missing data 
in those with the poorest outcomes.4 However, the fact 
remains that missing data were a feature of this study, and 
potential improvements to the way data are recorded in 
the NICR are continuously being made. The study inves-
tigated a broad range of factors that may be associated 
with early death and allowed for adjustment of a range 
of confounding factors such as comorbidity, smoking 
and alcohol status. We present results from both univar-
iate and multivariate analyses but place greater emphasis 
on the results from the multivariate analysis due to the 
complex nature of interacting factors causing early death 
from colon cancer. The recording of the patient charac-
teristics that vary over time at between 1 and 3 years before 
diagnosis was an important feature of the study design. 
Cancer diagnosis has been previously identified as being 
associated with changes in health-seeking behaviour, 
comorbidity, BMI and lifestyle factors. Recording these 
factors based on over 1 year before diagnosis strengthens 
the assessment of causal inference between variables and 
early death.
The case–control design of the study provided an 
efficient methodology to collect data and allowed the 
development of a control group that was matched on 
important but non-modifiable characteristics. While age, 
sex and year of diagnosis were fixed in the current study, 
their interaction with diagnostic pathway features and 
other characteristics could not be investigated. Previous 
studies have shown longer diagnostic timelines, later 
stage disease at diagnosis, lower symptom awareness and 
more negative cancer beliefs to be variable depending 
on age47 and sex.48 In addition, the matching on age may 
have reduced variation in other characteristics such as 
comorbidity. The study population was also selected in a 
period before the introduction of screening; therefore, 
all patients in both the case and control groups were clin-
ically diagnosed. While bowel screening was introduced 
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in NI in 201122 and now represents an important pathway 
in cancer diagnosis, the majority of patients are still diag-
nosed clinically and the early clinical detection of symp-
toms remains both important and relevant—particularly 
for cancer stage and, by extension, cancer survival. Future 
iterations of this work would likely benefit from matching 
of cases and controls on cancer stage, in addition to age, 
sex and year of diagnosis.
The use of a control group of longer survivors provided 
useful comparative information to investigate risk of early 
death, with the choice of a control sample of deceased 
patients with colon cancer removing any risk of consent 
bias from the study. However, while a buffer of 3 months 
was placed between cases and controls to allow better 
discrimination between the two, the survival of controls 
was restricted to a population of patients whose survival 
was less than 3 years and similar to the case population. 
Despite this, the study was able to identify several charac-
teristics which discriminated between cases and controls 
suggesting that the patients who die within the first few 
months of diagnosis are a specific patient cohort who 
requires attention.
COnClusIOns
This comprehensive study of early death from colon 
cancer has identified several population subgroups that 
warrant special attention. These include those who are 
single, living alone, older people living in rural environ-
ments, and people from the most deprived communi-
ties as well as those living in residential or nursing care. 
These likely comprise some of the most isolated people 
in society. However, while the aforementioned variables 
are an indicator of social isolation, this study was not 
designed to actually investigate isolation (ie, lack of social 
contact or poor social support networks). Therefore, 
further study is required to confirm that social isolation 
is definitely linked with poor cancer survival outcomes. 
Further studies are also required to better understand 
the role of missing data in patient records. Furthermore, 
additional work ought to be undertaken to determine 
if these patterns are consistent in other International 
Cancer Benchmarking Partnership (ICBP) countries. 
Finally, because of increased colon cancer survival, future 
studies investigating risk factors for an early death using 
a case–control methodology would likely benefit from 
comparing cases who suffer early mortality with controls 
who survive beyond 5 or perhaps even 10 years as opposed 
to the 3-year survival control group used in this study.49–51
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